Chapman University

Chapman University Digital Commons
Pharmacy Faculty Articles and Research

School of Pharmacy

2003

Hypertonic Stress Co-Stimulates T Cell Il-2
Expression Through a Feedback Mechanism
Involving ATP Release and P2 Receptor Activation
of P38 Map Kinase
William H. Loomis
University of California, San Diego

Sachiko Namiki
University of California, San Diego

Rennolds S. Ostrom
Chapman University, rostrom@chapman.edu

Paul A. Insel
University of California, San Diego

Wolfgang G. Junger
University of California, San Diego

Follow this and additional works at: http://digitalcommons.chapman.edu/pharmacy_articles
Part of the Amino Acids, Peptides, and Proteins Commons, Cell Biology Commons, and the
Other Pharmacy and Pharmaceutical Sciences Commons
Recommended Citation
William H. Loomis, Sachiko Namiki, Rennolds S Ostrom, Paul A. Insel, Wolfgang G. Junger. Hypertonic stress co-stimulates T cell
IL-2 expression through a feedback mechanism involving ATP release and P2 receptor activation of p38 MAP kinase. J Biol Chem,
278(7):4590-6, 2003.

This Article is brought to you for free and open access by the School of Pharmacy at Chapman University Digital Commons. It has been accepted for
inclusion in Pharmacy Faculty Articles and Research by an authorized administrator of Chapman University Digital Commons. For more information,
please contact laughtin@chapman.edu.

Hypertonic Stress Co-Stimulates T Cell Il-2 Expression Through a
Feedback Mechanism Involving ATP Release and P2 Receptor Activation
of P38 Map Kinase
Comments

This article was originally published in Journal of Biological Chemistry, volume 278, issue 7, in 2003. DOI:
10.1074/jbc.M207868200
Copyright

American Society for Biochemistry and Molecular Biology

This article is available at Chapman University Digital Commons: http://digitalcommons.chapman.edu/pharmacy_articles/374

THE JOURNAL OF BIOLOGICAL CHEMISTRY
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

Vol. 278, No. 7, Issue of February 14, pp. 4590 –4596, 2003
Printed in U.S.A.

Hypertonic Stress Increases T Cell Interleukin-2 Expression
through a Mechanism That Involves ATP Release,
P2 Receptor, and p38 MAPK Activation*
Received for publication, August 2, 2002, and in revised form, November 20, 2002
Published, JBC Papers in Press, December 2, 2002, DOI 10.1074/jbc.M207868200

William H. Loomis‡, Sachiko Namiki‡, Rennolds S. Ostrom§, Paul A. Insel§¶,
and Wolfgang G. Junger‡储
From the Departments of ‡Surgery/Trauma, §Pharmacology, and ¶Medicine, University of California
San Diego Medical Center, San Diego, California 92103

Hypertonic stress (HS)1 increases cytokine expression of immune cells and enhances T cell proliferation (1, 2). Peripheral
blood mononuclear cells show increased production of IL-1␣,
IL-1␤, IL-8, and tumor necrosis factor-␣ when the cells are
exposed to elevated extracellular tonicity (3). Hypertonic stimulation augments the ability of T cells to produce IL-2, tumor
necrosis factor-␣, and lymphotoxin-␤ (2, 4) and restores IL-2
expression in the presence of anti-inflammatory mediators (5).
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1
The abbreviations and trivial names used are: HS, hypertonic
stress; ATP␥S, adenosine 5⬘-O-(3-thiotriphosphate); KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine; o-ATP,
oxidized ATP; PBMC, peripheral blood mononuclear cells; PPADS, pyridoxalphosphate-6-azophenyl-2⬘,4⬘-disulfonic acid; MAPK, mitogenactivated protein kinase; PHA, phytohemagglutinin; IL, interleukin.

tients, who are predisposed to septic complications, and can
improve T cell function after hemorrhagic shock, reducing the
risk of sepsis after trauma (1, 6).
The enhancing effect of HS on IL-2 expression is paralleled
by robust tyrosine phosphorylation of a number of intracellular
proteins including p38 MAPK (2). This kinase is structurally
related to the yeast protein HOG-1, which is part of the signaling system that allows yeast cells to regulate gene transcription in response to osmotic stress (7). In human T cells, p38
MAPK signaling is involved in the activation of IL-2 gene
expression (8). Therefore, by analogy with its yeast counterpart, osmotic activation of the p38 MAPK may be involved in
the mechanisms whereby HS enhances IL-2 expression of T
cells.
In yeast, two osmoreceptors are known to activate HOG-1.
No equivalent mammalian osmoreceptors have been identified
to date, and, thus, the mechanisms whereby T cells respond to
extracellular tonicity are unclear (7). HS results in cell shrinkage and mechanical deformation of the cell membrane. In a
number of cell types, mechanical stress activates multiple signaling enzymes, including p38 MAPK (9, 10). Thus, the mechanisms by which these cells detect and respond to direct mechanical stimulation may be similar to those involved in the
recognition of HS.
Mechanical stimulation can cause the rapid release of ATP
(11–13). Once released into the extracellular environment, ATP
can regulate cell function in an autocrine/paracrine manner by
interacting with P2X and/or P2Y receptors that are expressed
on the surface of virtually all mammalian cells (13–16). Extracellular ATP and its metabolic products, including adenosine,
which acts via P1 receptors, exert a strong influence on lymphocyte function: ATP can stimulate the proliferation of mouse
thymocytes, and ATP and adenosine can antagonize and/or
complement T cell receptor-induced signaling, apoptosis, and
thymocyte differentiation (16 –18). In this study, we tested the
hypothesis that ATP release in response to osmotic stimulation
could be a mechanism whereby HS enhances IL-2 expression of
T cells.
EXPERIMENTAL PROCEDURES

Materials—ATP and a nonhydrolyzable ATP analog, ATP␥S, suramin, apyrase, adenosine deaminase, and Me2SO were from Sigma,
whereas 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62), 2⬘,3⬘-dialdehyde ATP (oxidized ATP, o-ATP),
pyridoxalphosphate-6-azophenyl-2⬘,4⬘-disulfonic acid (PPADS), and
SB203580 were from Calbiochem. The Ca2⫹-sensitive intracellular
probe Fura-2 was obtained from Molecular Probes, Inc. (Eugene, OR).
Antibodies to CD3 were purified from the supernatant of OKT-3 cells
(clone CRL 8001) obtained from ATCC and anti-CD28 antibodies (clone
CD28.2) were from BD Pharmingen (San Diego, CA). Polyclonal goat
anti-P2X7 antibodies were from Santa Cruz Biotechnology, Inc. (Santa
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Hypertonic stress (HS) can alter the function of mammalian cells. We have reported that HS enhances differentiated responses of T cells by increasing their ability
to produce interleukin (IL)-2, a finding of clinical interest because hypertonic infusions may modulate immune
function in patients. HS shrinks cells and mechanically
deforms membranes, which results in ATP release from
many cell types. Here we investigate if ATP release is an
underlying mechanism through which HS augments T
cell function. We found that mechanical stress and HS
induced rapid ATP release from Jurkat T cells. HS and
exogenous ATP mobilized intracellular Ca2ⴙ, activated
p38 MAPK, and increased IL-2 expression. Ca2ⴙ mobilization was attenuated in the presence of EGTA or by
removal of extracellular ATP with apyrase. Adenosine
did not increase IL-2 expression, as did ATP. Apyrase,
inhibition of P2 receptors, or inhibition of p38 MAPK
with SB203580 reduced the stimulatory effects of HS,
indicating that HS enhances IL-2 expression through a
mechanism that involves ATP release, P2 (perhaps
P2X7) receptors, and p38 MAPK activation. We conclude
that release of and response to ATP plays a key role in
the mechanism through which hypertonic stress regulates the function of T cells.

Hypertonic Co-stimulation of T Cells Involves ATP Release

for 5 min at 4 °C. The supernatant was centrifuged at 5,000 ⫻ g for 10
min at 4 °C, resulting in a pellet containing a crude membrane preparation. Purified plasma membrane preparations were obtained by
density gradient centrifugation of the cell homogenate using 30%
Percoll at 64,000 ⫻ g for 30 min. The crude and purified membrane
preparations were boiled in SDS sample buffer and subjected to SDSPAGE and immunoblotting with goat anti-P2X7 antibodies (Santa Cruz
Biotechnology).
For immunostaining, cells were attached to microscope slides by
cytocentrifugation, fixed with chilled acetone for 10 s, and dried. Then
the cells were blocked with 10% normal horse serum in phosphatebuffered saline for 20 min and incubated with 20 g/ml goat anti-P2X7
antibody in 10% horse serum for 1 h. The cells were washed with
phosphate-buffered saline, incubated for 10 min with biotinylated horse
anti-goat IgG antibody in 10% horse serum, washed with phosphatebuffered saline, and incubated for another 10 min with fluorescein
avidin D cell sorter grade conjugate according to the supplier’s recommendations. The cells were washed five times with phosphate-buffered
saline, mounted with Crystal/Mount (Biomeda Corp., Foster City, CA),
and examined with a fluorescence microscope (Leica, Wetzlar,
Germany). Fluorescence and modulation contrast images were acquired
of cells that were stained with anti-P2X7 and of control cells that were
treated identically to the antibody-stained cells, except that the
primary anti-P2X7 antibody was omitted.
Statistical Analyses—Unless otherwise indicated, data are presented
as mean ⫾ S.D. Sets of data were compared with Student’s t test, using
p ⬍ 0.05 as the level of significance.
RESULTS

Mechanical Stimulation and HS Cause Rapid ATP Release—We first investigated whether mechanical stimulation
causes ATP release from Jurkat cells. Cells were suspended in
RPMI containing luciferase reagent, and ATP release was monitored on-line with a luminometer. Initially high luminescence
readings, indicative of ATP release due to cell handling, gradually decreased, reaching base-line levels within 150 min (Fig.
1A, left). When the cells were mechanically stimulated by gentle aspiration with a pipette four times, the luminescence signal rapidly peaked within 1 min and returned toward base-line
levels by 100 min. These results show that mechanical stimulation causes the release of ATP into the extracellular space.
The steady decline of luminescence readings after mechanical
stimulation indicates that ATP release ceases shortly after the
stimulus and that released ATP is hydrolyzed, presumably by
ectoapyrases, ecto-ATPases, and/or ecto-5⬘-nucleotidases expressed on the Jurkat cell surface (21).
Because HS causes rapid cell shrinkage, we hypothesized
that the associated mechanical forces could trigger ATP release
from T cells. We tested this possibility by monitoring ATP
release in response to increasing levels of HS. The addition of
hypertonic solutions rapidly released ATP in a concentrationdependent fashion (Fig. 1A, right). Peak luminescence signals
reached a maximum within 4 min and gradually decreased to
base-line readings with kinetics similar to those observed with
mechanical agitation. The peak ATP signal in response to stimulation with 80 mM hypertonicity was more than 3 times as
high as that observed in response to 40 mM hypertonicity. ATP
release was less pronounced in response to 160 mM, suggesting
that higher levels of hypertonicity may exert suppressive effects on ATP release.
The relation between HS levels and ATP release was further
examined by measuring ATP release using an approach similar
to that described by Yegutkin et al. (12), who prevented the
degradation of extracellular ATP with suramin, a drug that
blocks P2 receptors and also inhibits ecto-5⬘-nucleotidases.
These experiments confirmed that exposure to HS causes a fast
and dose-dependent increase in extracellular ATP. The addition of an equivalent volume of isotonic control solution caused
a considerably smaller increase in extracellular ATP, which is
likely the result of mechanical perturbations caused by adding
this solution (Fig. 1B, left). ATP release increased with hyper-
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Cruz, CA), and normal horse serum, biotinylated anti-goat antibodies,
and fluorescein avidin D cell sorter grade conjugate were from Vector
Laboratories (Burlingame, CA).
Cells and Cell Stimulation—Jurkat T cells (clone E6 –1) were obtained from the American Type Culture Collection (Manassas, VA) and
maintained in RPMI 1640 (Irvine Scientific, Santa Ana, CA) supplemented with 100 units/ml penicillin, 100 g/ml streptomycin (University of California San Diego core facility, La Jolla, CA), and 10% (v/v)
heat-inactivated fetal calf serum (Irvine Scientific). Peripheral blood
mononuclear cells (PBMC) were isolated from the heparinized venous
blood of healthy human volunteers as described before (5).
Jurkat cells were stimulated by simultaneously activating the T cell
receptor-CD3 complex and CD28 co-receptor with Dynabeads (Dynal
Inc., Lake Success, NY) coated with anti-CD3 and anti-CD28 antibodies. The beads (107), precoated with anti-mouse IgG, were coated with
anti-CD3 and anti-CD28 by incubation with 5 g of each antibody at
room temperature for 1 h. Then the beads were washed twice with
RPMI with 10% fetal calf serum and resuspended at 107 beads/ml, and
20 l was added to 2 ⫻ 104 Jurkat cells (10 beads/cell). The cells were
incubated in a final volume of 200 l for 20 h at 37 °C under tissue
culture conditions, and IL-2 in the supernatant was determined. PBMC
were suspended in the RPMI medium described above (105/ml) and
stimulated under tissue culture conditions with 0.5 g/ml phytohemagglutinin (PHA; Abbott) in a final volume of 200 l for 20 h. IL-2
concentrations in the supernatants were determined with the enzymelinked immunosorbent assay method described below.
Where indicated, cells were pretreated for 1 h at 37 °C with different
agents including P1 and P2 receptor antagonists or the p38 MAPK
inhibitor SB203580 (19). Cells were subjected to HS by adding appropriate volumes of RPMI containing 1 M NaCl. All materials and compounds used in these experiments were sterile and endotoxin-free.
ATP Release—ATP release from Jurkat cells was monitored in real
time with cells suspended in luciferase reagent. Cells were brought to a
density of 5 ⫻ 105/ml in RPMI without fetal calf serum, and 25 l/well
was transferred to a 96-well luminometer plate. Luciferase reagent in
RPMI (25 l/well) was then added (ATP Bioluminescence Assay Kit
CLS II; Roche Diagnostics GmbH, Mannheim, Germany). The plate was
placed in a temperature-controlled luminometer (Luminoskan; Labsystems, Helsinki, Finland), and sequential readings were taken as
indicated. For quantitative ATP measurements, cells were preincubated for 3 h at 37 °C and stimulated with hypertonic saline for different periods. The cells were then placed on ice, and ATP concentrations
in the supernatants were determined.
IL-2 Expression—IL-2 released into the supernatants after 20 h was
measured with an enzyme-linked immunosorbent assay using monoclonal mouse anti-human IL-2 as a primary antibody (clone 5355.111)
and biotinylated goat anti-human IL-2 as a secondary antibody (both
from R&D Systems Inc., Minneapolis, MN), recombinant human IL-2 as
a standard (Genzyme Diagnostics, Cambridge, MA), and horseradish
peroxidase-conjugated streptavidin (Zymed Laboratories Inc., San
Francisco, CA). The enzyme-linked immunosorbent assay was performed according to the recommendations provided by R&D Systems.
p38 MAPK Expression and Activation—To measure p38 MAPK activation, Jurkat cells (106 cells/sample) stimulated in the different experiments were placed on ice, centrifuged, resuspended in 100 l of ice-cold
SDS sample buffer containing 100 mM dithiothreitol, and lysed by
boiling for 5 min. The cell lysates were separated by SDS-PAGE electrophoresis using 8 –16% Tris/glycine polyacrylamide gradient gels
(Novex, San Diego, CA). Lysed proteins were transferred to polyvinylidene difluoride membranes (Immobilon-P; Millipore Corp., Bedford,
MA), and the membranes were subjected to immunoblotting with phospho-specific antibodies that recognize the phosphorylated (on Thr180/
Tyr182), and thereby activated, form of p38 MAPK (New England Biolabs, Beverly, MA). Antibodies recognizing both active and inactive p38
MAPK were from Santa Cruz Biotechnology, and secondary antibody
conjugates as well as the ECL assay kit were from Amersham
Biosciences.
Intracellular Ca2⫹ Measurements—Intracellular Ca2⫹ levels were
determined as described previously (20) using the fluorescent Ca2⫹
probe Fura-2 and a spectrofluorimeter (Kontron Instruments, Zurich,
Switzerland). In experiments, where extracellular Ca2⫹ was chelated,
EGTA (Calbiochem) was added at a final concentration of 10 mM.
P2X7 Receptor Expression—Expression of the P2X7 receptor in Jurkat cells was determined by immunoblotting of cell membrane fractions
and by immunofluorescence staining. Cells were washed in ice-cold
phosphate-buffered saline, resuspended in 5 ml of homogenization
buffer (30 mM HEPES, 5 mM MgCl2, 1 mM EGTA, and 2 mM dithiothreitol, pH 7.5), homogenized with a sonicator, and centrifuged at 300 ⫻ g
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tonicity levels peaking at 80 mM HS (Fig. 1B, right).
HS and Extracellular ATP Co-stimulate IL-2 Expression—
The similarities between ATP release and other T cell responses to HS suggested that ATP release could be involved in
the mechanisms whereby HS enhances IL-2 expression. To test
this possibility, Jurkat cells were stimulated with antibodies to
CD3 and CD28 in the presence of increasing levels of HS or
exogenous ATP, and IL-2 production was measured 20 h later.
HS at concentrations up to 60 mM increased IL-2 expression of
Jurkat cells and isolated PBMC, whereas higher levels of HS
suppressed IL-2 production (Fig. 2A). Similar to HS, the addition of exogenous ATP significantly increased IL-2 expression
of Jurkat cells in a concentration-dependent fashion (Fig. 2B,
left). ATP concentrations of 10 – 40 M significantly increased
IL-2 expression. As with increasing levels of HS, higher concentrations of ATP progressively reduced the enhancement of
IL-2 expression. The nonhydrolyzable ATP analog ATP␥S also
enhanced IL-2 expression, doubling IL-2 expression at concentrations of ⱖ20 M (Fig. 2B, left). In contrast to the results with
ATP and HS, we observed no bimodal effect at higher concentrations of ATP␥S. UTP at concentrations between 0.02 and 1

FIG. 2. HS and ATP enhance IL-2 expression. Jurkat cells (A, left)
and isolated human PBMC (A, right) were stimulated in the presence of
increasing HS concentrations with anti-CD3/CD28 antibodies or PHA,
respectively, and IL-2 expression was determined after 20 h. B, the
effects of exogenous ATP, ATP␥S (left), UTP, ADP, and adenosine
(ADO; right) on IL-2 expression of anti-CD3/CD28-stimulated Jurkat
cells was determined. The results shown are representative of three
individual experiments, and values are expressed as mean ⫾ S.D. of
triplicate determinations; asterisks indicate statistically significant differences from control values in the absence of HS or nucleotides (*, p ⬍
0.05; **, p ⱕ 0.01).

M also enhanced IL-2 expression, whereas ADP and adenosine
(ADO) had no discernible effects (Fig. 2B, right). These data
demonstrate that certain nucleotides, but not ADP and adenosine, can co-stimulate IL-2 expression, supporting the notion
that activation of specific nucleotide receptors may contribute
to the regulation of T cell function by HS.
HS and ATP Cause Ca2⫹ Mobilization—Extracellular nucleotides, such as ATP, act via plasma membrane P2Y and P2X
receptors (14, 16, 18). Activation of both receptor types results
in intracellular Ca2⫹ mobilization. To test whether exposure of
Jurkat cells to HS or ATP could elicit intracellular Ca2⫹ mobilization, we loaded Jurkat cells with the Ca2⫹ probe Fura-2 and
assessed [Ca2⫹] in response to HS or the addition of ATP. HS
rapidly and concentration-dependently increased intracellular
[Ca2⫹] in Jurkat cells (Fig. 3A, left). This response was blunted
when extracellular ATP was hydrolyzed with apyrase or when
extracellular Ca2⫹ was bound with EGTA (Fig. 3A, right). The
peak Ca2⫹ concentrations corresponded to the applied levels of
HS and were consistently reduced by apyrase (Fig. 3B). Exogenous ATP and ATP␥S mobilized Ca2⫹ over a similar time
course (Fig. 3C). Whereas 0.5–1.0 mM ATP was required to
mobilize calcium, ⬃100-fold lower concentrations of ATP␥S
increased intracellular [Ca2⫹], suggesting that much of the
added ATP may be hydrolyzed before it can activate P2 receptors on the T cell membrane. Together, these findings suggest
that HS-promoted ATP release can trigger secondary signaling
events, such as Ca2⫹ mobilization via activation of purinergic
receptors, which may be involved in the up-regulation of IL-2
expression by HS.
HS Enhances IL-2 Expression via Released ATP—As a further test of the idea that ATP released in response to HS
augments the ability of CD3/CD28-stimulated T cells to ex-
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FIG. 1. HS causes rapid ATP release and enhances IL-2 expression. A, ATP release from Jurkat T cells suspended in luciferase reagent was monitored in a plate luminometer. Cells (1.25 ⫻ 104) suspended in RPMI containing luciferase reagent were pipetted into the
wells of a 96-well plate and left undisturbed until luminescence readings returned to base-line levels (shown in left panel). At time point 0
min, the cells were mechanically agitated by gently pipetting the cell
suspensions up and down four times (left) or exposed to osmotic stress
by adding equal volumes of RPMI containing additional NaCl to increase the final tonicity of the culture medium by 0, 40, 80, or 160 mM
(right). The results shown are representative of three experiments
performed on different days, and values (relative luminescence units
(RLU)) are expressed as the mean ⫾ S.D. of triplicate determinations.
B, ATP released into the culture supernatant was determined with a
commercially available ATP bioluminescence assay kit. Jurkat T cells
(5 ⫻ 106/ml) were allowed to rest for 3 h at 37 °C before they were
osmotically stimulated with 100 mM HS (left) or the indicated hypertonicity levels (right) in the presence of 200 M suramin to prevent ATP
degradation. ATP concentrations in the culture supernatants of quadruplicate samples were determined at the indicated time points (left) or
after 5 min (right). The results shown consist of the average ⫾ S.D. of
three experiments that were performed on different days. The asterisks
indicate statistically significant differences from isotonic control values
(*, p ⫽ 0.001; **, p ⬍ 0.001).
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press IL-2, we exposed CD3/CD28-stimulated Jurkat cells to
HS in the presence of apyrase, an enzyme that scavenges
extracellular ATP (22). Apyrase concentration-dependently reduced the co-stimulatory effects of HS (Fig. 4A). At a concentration of 20 units/ml, apyrase almost completely prevented the
enhancement of IL-2 expression by increasing levels of HS (Fig.
4B). These data are consistent with the idea that ATP released
into the extracellular space plays a critical role in the events
that lead to enhanced IL-2 expression in the presence of HS. As
a second approach to examine the role of ATP release in the
enhancement of IL-2 expression, we used the P2 receptor antagonist, suramin, which nonselectively blocks P2 receptors
and, in addition, as noted above, inhibits ecto-ATPases (14).
Suramin significantly reduced the enhancing effects of HS on
IL-2 production (Fig. 4C). ATP can be hydrolyzed to adenosine
by ectoenzymes (17), and we investigated whether adenosine
might be involved in the enhancing effects of HS on IL-2 production. The addition of adenosine deaminase to hydrolyze
adenosine did not alter the effect of HS on IL-2 expression (Fig.
4D). This suggests that ATP but not adenosine is responsible
for the enhancing effects of HS.
Role of P2X7 Receptors—Stimulation of P2X7 receptors has
been reported to increase intracellular [Ca2⫹] and to synergize
T cell proliferation in response to mitogens, such as PHA (18).
We used two approaches, immunoblotting of membranes (Fig.
5A) and immune fluorescence analysis of cells (Fig. 5B), and
found that Jurkat T cells express P2X7 receptors. In addition,
we tested the role of P2X7 in the response of T cells to HS using
the P2 receptor antagonists KN-62, o-ATP, and PPADS, all of
which antagonize P2X7 receptors (14). Jurkat T cells or isolated PBMC were treated with increasing concentrations of

FIG. 4. Extracellular ATP is required for the enhancement of
IL-2 expression by HS. Jurkat cells were stimulated with bead-bound
anti-CD3/CD28 antibodies in the presence of the indicated HS levels
and of increasing concentrations of apyrase (A) or of 20 units/ml apyrase
(B) to break down released ATP, in the presence (empty symbols) or
absence (filled symbols) of 200 M suramin to block P2 receptors (C) or
in the presence (empty symbols) or absence (filled symbols) of 1 unit/ml
adenosine deaminase (ADA). IL-2 production was determined as described above. Results are representative of three individual experiments, and data are means ⫾ S.D. of triplicate determinations. Asterisks indicate significant differences between treated versus untreated
samples (B and C) and HS versus isotonic controls (A) (*, p ⬍ 0.05; **,
p ⱕ 0.01).

these antagonists for 20 min, exposed to 40 mM HS, and stimulated with CD3/CD28 or PHA, respectively. With IC50 values
of about 0.1 M, KN-62 was the most potent of the three
compounds in reducing the effect of HS on IL-2 production (Fig.
5C). PPADS and o-ATP also reduced IL-2 expression, although
higher antagonist concentrations were needed; both PPADS
and o-ATP suppressed IL-2 expression of PBMC beyond the
IL-2 expression level reached under isotonic conditions (dashed
line). PBMC preparations consist not only of T cells but also of
B cells and monocytes; the antagonists may affect P2 receptors
in these other cells that serve as accessory cells to T cells. The
inhibitory effect by o-ATP was observed with both Jurkat and
peripheral T cells, suggesting that o-ATP may not only affect
the P2X7 receptor but also perhaps other P2 receptors that
influence T cell activation under normal, isotonic conditions.
ATP, Like HS, Activates p38 MAPK—HS is known to activate p38 MAPK in T cells (2). Because p38 MAPK signaling
targets several nuclear factors that may be responsible for T
cell gene regulation, we tested whether p38 MAPK contributes
to the mechanisms through which HS enhances IL-2 expression. We thus compared the roles of p38 MAPK signaling in
response to stimulation with ATP or HS. HS levels of 20, 40,
and 100 mM activated p38 MAPK in a concentration- and
time-dependent fashion (Fig. 6A). p38 MAPK activation was
detectable at 40 and 100 mM hypertonicity by 3 min, but the
highest activation levels were observed 30 – 60 min after stimulation with HS. Stimulation of T cells with ATP caused a less
pronounced activation of p38 MAPK with a peak at 1 min (Fig.
6B). ATP concentrations between 0.01 and 1 M were most
effective in the stimulation of p38 MAPK activation (Fig. 6C).
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FIG. 3. HS and ATP mobilize intracellular Ca2ⴙ. Jurkat T cells
were loaded with the Ca2⫹ probe Fura-2, exposed to the indicated levels
of HS (A, left panel) or to HS (300 mM) in the presence or absence of
apyrase or EGTA (A, right panel), and Ca2⫹ mobilization was recorded.
Peak intracellular Ca2⫹ levels in the presence or absence of apyrase
were plotted versus the corresponding HS levels (B). For comparison,
Ca2⫹ mobilization in response to stimulation with the indicated concentrations of ATP or ATP␥S was determined (C). Data shown are representative of three different experiments with similar results.
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These data show that extracellular ATP can trigger p38 MAPK
activation and that ATP release in response to hypertonic
stimulation of T cells may contribute to HS-promoted activa-

tion of p38 MAPK. A reason for the different kinetics and
amplitudes of p38 MAPK stimulation by HS and ATP may be
the prolonged nature of hypertonic stimulation compared with
stimulation with ATP.
p38 MAPK Is an Important Element in the Mechanism
whereby HS Enhances IL-2 Expression—The findings above
suggest that p38 MAPK signaling may contribute to the enhancement of IL-2 expression by HS and ATP. We thus inhibited p38 MAPK with the inhibitor SB203580 and investigated
whether this would prevent the enhancing effects of HS on
CD3/CD28-stimulatedIL-2expression.SB203580concentrationdependently reduced the enhancement of IL-2 expression by 40
mM hypertonicity. Increasing concentrations of SB203580 also
reduced IL-2 expression of cells stimulated in the absence of HS
(Fig. 7). The latter finding corresponds to earlier reports that
suggested a role of p38 MAPK in the activation of IL-2 expression of Jurkat cells (8). SB203580 completely abrogated the
enhancement of IL-2 expression by a wide range of HS conditions (Fig. 7). These results imply that p38 MAPK plays a
major role in the enhancement of IL-2 expression by HS.
DISCUSSION

FIG. 6. HS and ATP activate p38 MAPK in Jurkat cells. Timing of p38 MAPK activation by HS (A) and ATP (B) and the dose response to
ATP stimulation were determined by stimulating Jurkat cells with the indicated levels of HS or ATP for different periods or for 5 min (C). p38
MAPK activation was determined by immunoblotting with phosphospecific anti-p38 MAPK antibodies (upper lanes). To control for equal protein
loading, membranes were reprobed with antibodies recognizing active and inactive p38 MAPK (lower lanes). Band intensities were analyzed, and
ratios between activated and total p38 MAPK were used to calculate p38 MAPK activation. In B and C, cells were stimulated with 100 mM HS as
a positive controls. The data shown are representative of three experiments with similar results.
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FIG. 5. P2X7 receptor expression and action in Jurkat cells
and PBMC. Jurkat cells express P2X7 as shown by immunoblotting of
crude membranes (MB) and purified membranes (PM) of Jurkat cells
(A) and in the fluorescence image of Jurkat cells stained with P2X7
antibodies (B, upper panels) or control cells that were stained without
P2X7 antibodies (B, lower panel). Jurkat cells (C, left) or isolated human
PBMC (C, right) were pretreated for 20 min with the indicated concentration of the P2X7 antagonist PPADS, o-ATP, or KN-62, stimulated with
40 mM HS and anti-CD3/CD28 or PHA, respectively. IL-2 production was
determined as in Fig. 2 and is expressed as a percentage of the IL-2
production of control cells that were stimulated in the absence of HS.

Under normal physiological conditions, plasma tonicity can
vary significantly as a consequence of water loss and salt uptake. Plasma tonicity is affected by age (23), climate, and seasonal changes (24) and by activities such as water/salt uptake
and physical exercise (25, 26), the latter of which can affect the
ratio of T cell subsets in the circulation (25). Whereas these
external influences can alter plasma tonicity, even more extreme differences in extracellular tonicity occur within the
organs of the gastrointestinal and urinary tract. It is possible
that elevated tonicity could increase the level of vigilance of the
immune cells patrolling these organs.
Aside from HS, other conditions leading to cellular distress
can result in ATP release (e.g. tissue injury or hypoxia during
hemorrhagic shock) (27). ATP and its metabolites may allow
the host to better cope with injury by increasing T cell function.
Indeed, administration of ATP-MgCl2 or inhibition of adenosine kinase has been shown to improve survival after hemor-
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FIG. 7. Osmotic regulation of IL-2 expression involves ATP
release and p38 MAPK. Jurkat T cells were treated for 1 h at 37 °C
with either the indicated doses of the p38 MAPK inhibitor SB203580
(left), 20 M SB203580, or Me2SO vehicle only (no SB203580) (right).
The cells were then stimulated via CD3/CD28 in the absence or presence of HS as indicated, and IL-2 production was determined. Data are
representative of three different experiments and expressed as mean ⫾
S.D. (*, p ⬍ 0.03; **, p ⬍ 0.001, n ⫽ 3).

FIG. 8. Proposed mechanism of hypertonic regulation of IL-2
expression. We propose that HS enhances IL-2 expression of T cells
via osmotic cell shrinkage, membrane deformation, ATP release into
the extracellular space, the activation of P2X7 by ATP, and subsequent
Ca2⫹ mobilization and p38 MAPK activation. These signals then increase IL-2 gene transcription and expression.

found that Jurkat cells express P2X7 and that P2X7-specific
antagonists can attenuate the enhancing effect of HS on IL-2
expression (Fig. 5). These observations suggest that P2X7 may
play an important role in the response of T cells to HS.
HS triggered robust Ca2⫹ mobilization at HS levels that
increased extracellular ATP concentrations to ⬃2 M (Fig. 1B).
In comparison, much higher concentrations of exogenous ATP
were required for equivalent increases of intracellular Ca2⫹
levels (Fig. 3) or p38 MAPK activation (Fig. 6). This discrepancy could be due to differences of the ATP concentrations in
proximity to the T cell membrane compared with the bulk
media. Extracellular nucleotides can be hydrolyzed by ectoATPases and ecto-5⬘-nucleotidases that exist on the plasma
membrane of cells (21, 34); our data (Fig. 1) suggest the presence of such enzymes on Jurkat cells. ATP released in response
to hypertonic stimulation is likely to achieve its highest concentrations in close proximity to the plasma membrane (i.e.
adjacent to P2 receptors) (35). This explanation is consistent
with our observation that nonhydrolyzable ATP␥S was about
50 times as effective as ATP in triggering Ca2⫹ mobilization in
Jurkat cells. Mechanical stimulation of other cell types causes
ATP release and the propagation of Ca2⫹ waves along monolayers, indicating that ATP-induced Ca2⫹ signaling can serve
as a means of communication between neighboring cells (36).
Our data suggest that HS-induced ATP release may also serve
as messenger between osmotically stressed cells.
p38 MAPK is activated by cellular stresses, inflammatory
cytokines, lipopolysaccharide, and G protein-coupled receptors
(37, 38). Activated p38 MAPK in turn mediates cytokine pro-
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rhagic shock and sepsis and to protect lungs from ischemia
reperfusion injury (27–29). Because of its protective effects, the
ATP metabolite, adenosine, has been termed the “retaliatory
metabolite in ischemia-reperfusion” (27).
In trauma patients, hypertonic solutions can be used to rapidly restore lost blood volume (6). The infusion of these solutions transiently increases plasma tonicity to levels that we
report here to cause substantial ATP release from T cells. As
observed with ATP-MgCl2 administration, hypertonic solutions
can improve the outcome after hemorrhagic shock and sepsis in
both animal models and patients (1, 6). The present study
suggests that ATP release in response to hypertonic solutions
could mediate these beneficial in vivo effects by enhancing the
function of T cells.
It has long been recognized that cells release ATP under
pathological conditions that involve hypoxia, cell damage, loss
of cell viability, and cytolysis (14, 15). More recently, it has
been noted that healthy cells release ATP under normal physiological conditions. Mechanical and osmotic stimulation have
been shown to cause ATP release from several different cell
types including endothelial and epithelial cells, fibroblasts,
hepatocytes, and vascular smooth muscle cells (e.g. Refs. 12, 13,
30, and 31). There are at least three possible mechanisms for
the regulated release of nucleotides under physiological conditions: exocytosis of ATP-filled vesicles, conductive transport
through membrane ion channels, and facilitated diffusion by
nucleotide-specific transporters. However, work to date has not
precisely resolved which mechanism is operative (22, 30).
The present study demonstrates for the first time that mechanical agitation and exposure to HS stimulate Jurkat T
lymphocytes to release ATP in a manner that correlates with
the level of hypertonicity to which the cells are exposed (Fig. 1).
Similar ATP release patterns have been reported in response to
direct mechanical stimulation of endothelial and vascular
smooth muscle cells (13, 32). Exposure of mammalian cells to
HS causes rapid cell shrinkage, which is accompanied by membrane deformation. Modest mechanical forces of hemodynamic
origin and forces associated with increased perfusion flow rates
have been shown to trigger ATP release from vascular smooth
muscle and endothelial cells (15, 32, 33). Mechanical and hypertonic stimulation of T cells resulted in a rapid ATP release
followed by a decrease toward base-line levels (Fig. 1). This
decrease of extracellular ATP is presumed to occur via ATP
hydrolysis by ecto-ATPases and ecto-5⬘-nucleotidases, such as
CD39 and CD73, which may be expressed on the T cell membrane (18, 21). Other pathways for metabolism of extracellular
nucleotides have been identified recently (e.g. Ref. 34).
As with HS, the addition of exogenous ATP, its nonhydrolyzable analog ATP␥S, and UTP significantly increased the ability
of Jurkat cells to produce IL-2, and the addition of apyrase
blunted this response (Figs. 2 and 4). The results demonstrate
that ATP release in response to osmotic stimulation can enhance IL-2 expression in an autocrine/paracrine fashion that
probably involves P2 receptors expressed on the T cell surface.
The ATP product adenosine (ADO) did not influence IL-2 expression (Fig. 2B), and adenosine deaminase, a scavenger of
adenosine, did not reduce the enhancing effect of HS on IL-2
production (Fig. 4D), suggesting that adenosine and the adenosine or P1 receptors are not involved in the regulation of T cell
function by HS.
Based on their molecular structures, P2 receptors are divided into two subfamilies: the G protein-coupled heptahelical
P2Y receptors and P2X receptors that are ligand-gated ion
channels. Of the mammalian P2 receptors that have been
cloned to date (14), only P2X-like receptors (P2X1, P2X4, and
P2X7) seem to be expressed by human T lymphocytes (18). We
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duction and other stress responses (19, 38). p38 MAPK is also
activated by mechanical stimulation in a number of cell types
(e.g. Refs. 39 and 40). Mechanical stimulation of vascular
smooth muscle cells recently has been shown to activate p38
MAPK through a mechanism that involves ATP release and a
feedback mechanism involving extracellular ATP and adenosine (32). Our data suggest that a similar feedback mechanism
may be involved in the response of Jurkat T cells to HS (Fig. 6).
Inhibition of p38 MAPK with SB203580 prevented the enhancement of IL-2 expression by HS, consistent with the idea
that p38 MAPK signaling plays a critical role in the response of
T cells to HS.
Overall, our results suggest a regulatory pathway where HS
causes the release of ATP. ATP in turn activates P2 receptors
that increase Ca2⫹ influx and the activation of p38 MAPK.
Finally, p38 MAPK exerts a co-stimulatory signal that enhances IL-2 expression of CD3/CD28-stimulated T cells,
thereby enhancing T cell function (Fig. 8). Existence of this
pathway identifies new targets for the modulation of T cell
function.
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